Viking Therapeutics (VKTX) had the highest return between February 1, 2023 and April 30, 2023 by a mid-cap US stock, returning 141.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Viking Therapeutics (VKTX) | 2/1/2023 - 4/30/2023 | 141.88% |
Riot Blockchain (RIOT) | 2/1/2023 - 4/30/2023 | 91.67% |
MoonLake Immunotherapeutics (MLTX) | 2/1/2023 - 4/30/2023 | 78.24% |
Oscar Health (OSCR) | 2/1/2023 - 4/30/2023 | 75.72% |
Protagonist Therapeutics (PTGX) | 2/1/2023 - 4/30/2023 | 70.18% |
TG Therapeutics (TGTX) | 2/1/2023 - 4/30/2023 | 63.03% |
ELF Beauty (ELF) | 2/1/2023 - 4/30/2023 | 61.63% |
VEON (VEON) | 2/1/2023 - 4/30/2023 | 60.48% |
Apellis Pharmaceuticals (APLS) | 2/1/2023 - 4/30/2023 | 58.58% |
BridgeBio Pharma (BBIO) | 2/1/2023 - 4/30/2023 | 55.96% |
Lifestance Health (LFST) | 2/1/2023 - 4/30/2023 | 54.36% |
Vertex (VERX) | 2/1/2023 - 4/30/2023 | 51.84% |
Lantheus (LNTH) | 2/1/2023 - 4/30/2023 | 48.32% |
Goosehead Insurance (GSHD) | 2/1/2023 - 4/30/2023 | 47.97% |
Burford Capital (BUR) | 2/1/2023 - 4/30/2023 | 42.61% |
Cinemark (CNK) | 2/1/2023 - 4/30/2023 | 41.73% |
Hims Hers Health (HIMS) | 2/1/2023 - 4/30/2023 | 39.98% |
Intapp (INTA) | 2/1/2023 - 4/30/2023 | 39.18% |
Remitly Global (RELY) | 2/1/2023 - 4/30/2023 | 38.73% |
SkyWest (SKYW) | 2/1/2023 - 4/30/2023 | 37.11% |
UWM (UWMC) | 2/1/2023 - 4/30/2023 | 34.73% |
Stevanato Group SpA (STVN) | 2/1/2023 - 4/30/2023 | 34.71% |
Legend Biotech (LEGN) | 2/1/2023 - 4/30/2023 | 33.96% |
iRhythm Technologies (IRTC) | 2/1/2023 - 4/30/2023 | 33.67% |
Gulfport Energy Operating (GPOR) | 2/1/2023 - 4/30/2023 | 33.17% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
